ApicHope Pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of pharmaceutical drugs in China. The company offers pediatric medicines, such as fuganlin and yiqi jianpi oral liquids, carboxymestrine oral solutions, and xiao'er kechuanling oral liquid products; and clindamycin palmitate hydrochloride dispersible tablets, acetylkitasamycin for suspension, qinxiangqingjie oral liquids, epinastine hydrochloride granules, clindamycin palmitate hydrochloride granules, clindamyxin hydrochloride for injection, clindamycin phosphate injection, ambroxol hydrochloride drops, montelukast sodium oral granules, oseltamivir phosphate capsules, and levocetirizine dihydrochloride oral drops. It also provides chronic disease drugs, including aciclovir for injection, hepatocyte growth-promoting factor for injection, pentoxifylline injection, kangshen and niaoqingshu granules, shenbo lotion, compound monoammonium glycyrrhizinate s and lansoprazole for injection, omeprazole sodium for injection, and other products. In addition, the company offers compound elsholtzia liquid, yinhuang oral liquid, and xiongdan chuanbei oral liquid products; levofloxacin hydrochloride for injection, ketorolac trometamol injection, phloroglucinol injection, ibuprofen tablets, vidarabine monophosphate for injection, lexofloxacin tablets, tranexamic acid injection, ropivacaine hydrochloride injection, mecobalamin injection, linezolid for oral suspension, clindamyxin hydrochloride for injection, caspofungin acetate for injection, and tongxuan lifei tablets. Further, it engages in scientific research and technical services; wholesale and retail trade; information technology; and technology promotion and application services. The company was formerly known as ApicHope Pharmaceutical Co., Ltd and changed its name to ApicHope Pharmaceutical Group Co., Ltd. in December 2024. ApicHope Pharmaceutical Group Co., Ltd. was founded in 2002 and is headquartered in Guangzhou, China.